| Mary Kristine Ellis, MD | |
|
196 Merrick Rd, Oceanside, NY 11572-1420 | |
| (516) 255-8400 | |
| Not Available |
| Full Name | Mary Kristine Ellis |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 196 Merrick Rd, Oceanside, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134447329 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Sinai South Nassau | Oceanside, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mount Sinai School Of Medicine | 6406096544 | 154 |
News Archive
Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.
Doctations, Inc., an innovative leader in applying Internet technology to improve healthcare, today added its new Surveillance Program functionality to its groundbreaking online healthcare and medical practice management solution.
inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.
In September, when Texas' near-total abortion ban took effect, Planned Parenthood clinics in the Lone Star State started offering every patient who walked in information on Senate Bill 8, as well as emergency contraception, condoms and two pregnancy tests. The plan is to distribute 22,000 "empowerment kits" this year.
› Verified 7 days ago
| Entity Name | Wyckoff Professional Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659710796 PECOS PAC ID: 6406748607 Enrollment ID: O20040324001805 |
News Archive
Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.
Doctations, Inc., an innovative leader in applying Internet technology to improve healthcare, today added its new Surveillance Program functionality to its groundbreaking online healthcare and medical practice management solution.
inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.
In September, when Texas' near-total abortion ban took effect, Planned Parenthood clinics in the Lone Star State started offering every patient who walked in information on Senate Bill 8, as well as emergency contraception, condoms and two pregnancy tests. The plan is to distribute 22,000 "empowerment kits" this year.
› Verified 7 days ago
| Entity Name | Nyu Langone Hospitals |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790975944 PECOS PAC ID: 4981515699 Enrollment ID: O20050721000058 |
News Archive
Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.
Doctations, Inc., an innovative leader in applying Internet technology to improve healthcare, today added its new Surveillance Program functionality to its groundbreaking online healthcare and medical practice management solution.
inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.
In September, when Texas' near-total abortion ban took effect, Planned Parenthood clinics in the Lone Star State started offering every patient who walked in information on Senate Bill 8, as well as emergency contraception, condoms and two pregnancy tests. The plan is to distribute 22,000 "empowerment kits" this year.
› Verified 7 days ago
| Entity Name | City Medical Of Upper East Side Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801277629 PECOS PAC ID: 0648465039 Enrollment ID: O20101111000052 |
News Archive
Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.
Doctations, Inc., an innovative leader in applying Internet technology to improve healthcare, today added its new Surveillance Program functionality to its groundbreaking online healthcare and medical practice management solution.
inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.
In September, when Texas' near-total abortion ban took effect, Planned Parenthood clinics in the Lone Star State started offering every patient who walked in information on Senate Bill 8, as well as emergency contraception, condoms and two pregnancy tests. The plan is to distribute 22,000 "empowerment kits" this year.
› Verified 7 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609120674 PECOS PAC ID: 8224282926 Enrollment ID: O20130205000439 |
News Archive
Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.
Doctations, Inc., an innovative leader in applying Internet technology to improve healthcare, today added its new Surveillance Program functionality to its groundbreaking online healthcare and medical practice management solution.
inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.
In September, when Texas' near-total abortion ban took effect, Planned Parenthood clinics in the Lone Star State started offering every patient who walked in information on Senate Bill 8, as well as emergency contraception, condoms and two pregnancy tests. The plan is to distribute 22,000 "empowerment kits" this year.
› Verified 7 days ago
| Entity Name | Mount Sinai School Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508127531 PECOS PAC ID: 6406096544 Enrollment ID: O20130712000368 |
News Archive
Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.
Doctations, Inc., an innovative leader in applying Internet technology to improve healthcare, today added its new Surveillance Program functionality to its groundbreaking online healthcare and medical practice management solution.
inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.
In September, when Texas' near-total abortion ban took effect, Planned Parenthood clinics in the Lone Star State started offering every patient who walked in information on Senate Bill 8, as well as emergency contraception, condoms and two pregnancy tests. The plan is to distribute 22,000 "empowerment kits" this year.
› Verified 7 days ago
| Entity Name | Union Medical Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184066698 PECOS PAC ID: 6204067895 Enrollment ID: O20140325000067 |
News Archive
Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.
Doctations, Inc., an innovative leader in applying Internet technology to improve healthcare, today added its new Surveillance Program functionality to its groundbreaking online healthcare and medical practice management solution.
inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.
In September, when Texas' near-total abortion ban took effect, Planned Parenthood clinics in the Lone Star State started offering every patient who walked in information on Senate Bill 8, as well as emergency contraception, condoms and two pregnancy tests. The plan is to distribute 22,000 "empowerment kits" this year.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Kristine Ellis, MD 1 Healthy Way, Oceanside, NY 11572-1551 Ph: (516) 255-8400 | Mary Kristine Ellis, MD 196 Merrick Rd, Oceanside, NY 11572-1420 Ph: (516) 255-8400 |
News Archive
Ardea Biosciences, Inc. announced that additional positive data from its Phase 2 program for RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, are being presented at the Annual European Congress of Rheumatology hosted by the European League Against Rheumatism (EULAR) in Rome, Italy. RDEA594, a first-in-class selective inhibitor of the URAT1 transporter, treats the underlying cause of gout by increasing the excretion of uric acid in order to bring the body's levels of uric acid into a normal range.
Doctations, Inc., an innovative leader in applying Internet technology to improve healthcare, today added its new Surveillance Program functionality to its groundbreaking online healthcare and medical practice management solution.
inVentiv Health, Inc., a leading provider of outsourced clinical development, launch and commercialization services to the global healthcare industry, today announced that it has signed a definitive agreement to acquire Campbell Alliance, a leading management consulting firm specializing in serving the pharmaceutical and biotech industries. Yesterday, inVentiv announced that it has signed a definitive agreement to purchase i3 from Ingenix.
In September, when Texas' near-total abortion ban took effect, Planned Parenthood clinics in the Lone Star State started offering every patient who walked in information on Senate Bill 8, as well as emergency contraception, condoms and two pregnancy tests. The plan is to distribute 22,000 "empowerment kits" this year.
› Verified 7 days ago
Kenya Crafton, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Healthy Way, Oceanside, NY 11572 Phone: 516-632-3000 | |
Dr. Zeeshan Alam Khan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 196 Merrick Rd, Oceanside, NY 11572 Phone: 516-255-8400 | |
Dr. Lillian Carolina, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1 Healthy Way, Oceanside, NY 11572 Phone: 516-255-8400 | |
Jamil Uddin Ahmed, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Healthy Way, Oceanside, NY 11572 Phone: 516-632-3666 | |
Dr. Shara Rebecca Feltheimer, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Healthy Way, Oceanside, NY 11572 Phone: 516-632-3000 | |
Malcolm Forbes, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Healthy Way, Oceanside, NY 11572 Phone: 516-255-8414 |